EX-99.1
Por um escritor misterioso
Descrição
![EX-99.1](https://www.cabalettabio.com/investors/sec-filings/all-sec-filings/content/0001193125-23-228144/g436624ex99_1s1g1.jpg)
EX-99.1
![EX-99.1](https://www.sec.gov/Archives/edgar/data/794619/000119312521182943/g395914ex99_1s1g1.jpg)
EX-99.1
![EX-99.1](https://www.baudaxbio.com/news-and-investors/financial-and-filings/all-sec-filings/content/0001193125-19-306813/g841356ex99_1s1g1.jpg)
EX-99.1
![EX-99.1](https://www.pieris.com/investors/sec-filings/all-sec-filings/content/0001193125-16-425868/g106211ex99_1s2g1.jpg)
EX-99.1
![EX-99.1](https://ir.contrafect.com/sec-filings/content/0001193125-22-153619/g322525g05h00.jpg)
EX-99.1
![EX-99.1](https://www.sec.gov/Archives/edgar/data/1364250/000136425023000047/q2earningspackagecovera.jpg)
Douglas Emmett Inc - Executive Summary - EX-99.1 - August 01, 2023
![EX-99.1](https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-22-113033/g353305ex99_1s1g1.jpg)
EX-99.1
![EX-99.1](https://api.stock.us/edgar/files/8-K/1822993/000119312521248334/g171132dsp002.jpg)
EX-99.1
Kelan Padgett on LinkedIn: BRDG 2023.03.31 Ex 99.1 Earnings Press Release
![EX-99.1](https://www.inhibikase.com/investors/sec-filings/all-sec-filings/content/0001193125-22-246370/g386213dsp004.jpg)
EX-99.1
![EX-99.1](https://ir.pfholdingscorp.com/sec-filings/all-sec-filings/content/0001193125-23-044978/g415959ex99_1s1g1.jpg)
EX-99.1
de
por adulto (o preço varia de acordo com o tamanho do grupo)